Literature DB >> 17021055

Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women.

Carole Fakhry1, Gypsyamber D'souza, Elizabeth Sugar, Kathleen Weber, Eleni Goshu, Howard Minkoff, Rodney Wright, Eric Seaberg, Maura Gillison.   

Abstract

Human papillomavirus (HPV) is an etiologic agent for both oropharyngeal and cervical cancers, yet little is known about the interrelationship between oral and cervical HPV infections. Therefore, we compared the prevalences and type distributions of oral and cervical HPV infections and evaluated infection concordance in a cross-sectional study within the Women's Interagency HIV Study cohort. Oral rinse and cervical-vaginal lavage samples were concurrently collected from a convenience sample of 172 human immunodeficiency virus (HIV)-positive and 86 HIV-negative women. HPV genomic DNA was detected by PGMY09/11 L1 consensus primer PCR and type specified by reverse line blot hybridization for 37 HPV types and beta-globin. Only 26 of the 35 HPV types found to infect the cervix were also found within the oral cavity, and the type distribution for oral HPV infections appeared distinct from that for cervical infections (P<0.001). Oral HPV infections were less common than cervical infections for both HIV-positive (25.2% versus 76.9%, P<0.001) and HIV-negative (9.0% versus 44.9%, P<0.001) women. Oral HPV infections were more common among women with a cervical HPV infection than those without a cervical HPV infection (25.5% versus 7.9%, P=0.002). The majority of women (207; 93.7%) did not have simultaneous oral and cervical infections by the same HPV type; however, the number of women who did (14; 6.3%) was significantly greater than would be expected by chance (P=0.0002). Therefore, the oral and cervical reservoirs for HPV infection are likely not entirely independent of one another.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17021055      PMCID: PMC1698387          DOI: 10.1128/JCM.01321-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Association of cancer with AIDS-related immunosuppression in adults.

Authors:  M Frisch; R J Biggar; E A Engels; J J Goedert
Journal:  JAMA       Date:  2001-04-04       Impact factor: 56.272

3.  Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States).

Authors:  Anna R Giuliano; Rebecca L Sedjo; Denise J Roe; Robin Harri; Susie Baldwi; Mary R Papenfuss; Martha Abrahamsen; Paula Inserra
Journal:  Cancer Causes Control       Date:  2002-11       Impact factor: 2.506

4.  Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.

Authors:  Bengt Göran Hansson; Kerstin Rosenquist; Annika Antonsson; Johan Wennerberg; Elsy-Britt Schildt; Anna Bladström; Gunilla Andersson
Journal:  Acta Otolaryngol       Date:  2005-12       Impact factor: 1.494

5.  Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer.

Authors:  Jennifer S Smith; Rolando Herrero; Cristina Bosetti; Nubia Muñoz; F Xavier Bosch; José Eluf-Neto; Xavier Castellsagué; Chris J L M Meijer; Adriaan J C Van den Brule; Silvia Franceschi; Rhoda Ashley
Journal:  J Natl Cancer Inst       Date:  2002-11-06       Impact factor: 13.506

6.  Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix.

Authors:  M M Madeleine; J R Daling; S M Schwartz; K Shera; B McKnight; J J Carter; G C Wipf; C W Critchlow; J K McDougall; P Porter; D A Galloway
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-03       Impact factor: 4.254

Review 7.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

8.  Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.

Authors:  J Mork; A K Lie; E Glattre; G Hallmans; E Jellum; P Koskela; B Møller; E Pukkala; J T Schiller; L Youngman; M Lehtinen; J Dillner
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

9.  Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study.

Authors:  Nubia Muñoz; Silvia Franceschi; Cristina Bosetti; Victor Moreno; Rolando Herrero; Jennifer S Smith; Keerti V Shah; Chris J L M Meijer; F Xavier Bosch
Journal:  Lancet       Date:  2002-03-30       Impact factor: 79.321

10.  Determinants of genital human papillomavirus detection in a US population.

Authors:  C L Peyton; P E Gravitt; W C Hunt; R S Hundley; M Zhao; R J Apple; C M Wheeler
Journal:  J Infect Dis       Date:  2001-05-09       Impact factor: 5.226

View more
  50 in total

Review 1.  The role of HPV in head and neck cancer and review of the HPV vaccine.

Authors:  Gypsyamber D'Souza; Amanda Dempsey
Journal:  Prev Med       Date:  2011-10       Impact factor: 4.018

2.  Head and neck squamous cell carcinomas in HIV-positive patients: a preliminary investigation of viral associations.

Authors:  Michael S McLemore; Missak Haigentz; Richard V Smith; Gerard J Nuovo; Llucia Alos; Antonio Cardesa; Margaret Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2010-03-24

Review 3.  Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination.

Authors:  Maura L Gillison
Journal:  J Adolesc Health       Date:  2008-10       Impact factor: 5.012

4.  Concordance of Beta-papillomavirus across anogenital and oral anatomic sites of men: The HIM Study.

Authors:  Emily M Nunes; Rossana V M López; Staci L Sudenga; Tarik Gheit; Massimo Tommasino; Maria L Baggio; Silvaneide Ferreira; Lenice Galan; Roberto C Silva; Eduardo Lazcano-Ponce; Anna R Giuliano; Luisa L Villa; Laura Sichero
Journal:  Virology       Date:  2017-07-11       Impact factor: 3.616

5.  A Case of Rectal Squamous Cell Carcinoma with Metachronous Diffuse Large B Cell Lymphoma in an HIV-Infected Patient.

Authors:  Heun Choi; Hye Won Lee; Hea Won Ann; Jae Kyung Kim; Hua Pyong Kang; Sun Wook Kim; Nam Su Ku; Sang Hoon Han; June Myung Kim; Jun Yong Choi
Journal:  Infect Chemother       Date:  2014-12-29

6.  Oral Human Papillomavirus Infection and Oral Lesions in HIV-Positive and HIV-Negative Dental Patients.

Authors:  Katia Muller; Julie Kazimiroff; Mahnaz Fatahzadeh; Richard V Smith; Mauricio Wiltz; Jacqueline Polanco; Robert M Grossberg; Thomas J Belbin; Howard D Strickler; Robert D Burk; Nicolas F Schlecht
Journal:  J Infect Dis       Date:  2015-02-13       Impact factor: 5.226

7.  Rates and determinants of oral human papillomavirus infection in young men.

Authors:  Zoe R Edelstein; Stephen M Schwartz; Stephen Hawes; James P Hughes; Qinghua Feng; Michael E Stern; Sandra O'Reilly; Shu-Kuang Lee; Long Fu Xi; Laura A Koutsky
Journal:  Sex Transm Dis       Date:  2012-11       Impact factor: 2.830

Review 8.  Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma.

Authors:  Liviu Feller; Neil H Wood; Razia A G Khammissa; Johan Lemmer
Journal:  Head Face Med       Date:  2010-07-15       Impact factor: 2.151

9.  Oral human papillomavirus detection in older adults who have human immunodeficiency virus infection.

Authors:  Mahnaz Fatahzadeh; Nicolas F Schlecht; Zigui Chen; Danielle Bottalico; Sharod McKinney; Janae Ostoloza; Anne Dunne; Robert D Burk
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-01-31

10.  Epithelial maturation and molecular biology of oral HPV.

Authors:  Liviu Feller; Razia Ag Khammissa; Neil H Wood; Johan Lemmer
Journal:  Infect Agent Cancer       Date:  2009-11-25       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.